Web Images Videos Maps News Shopping Gmail more »
Sign in

Results 110 of about 275 for white blood cell medication. (0.20 seconds)
News

Neulasta® (pegfilgrastim)

www.Neulasta.com   Visit the Official Website to Learn About Neulasta and Receive Info.
Sponsored Links

ChemGenex Cancer Drug Helped Few Patients, FDA Says

BusinessWeek - Catherine Larkin, Simeon Bennett - ‎Feb 8, 2010‎
Chronic myeloid leukemia is a slow-progressing condition in which a genetic flaw triggers a person's bone marrow to produce too many white blood cells. ...

Cell Therapeutics' Last Hope for Survival, Dashed

Minyanville.com - Lisa LaMotta - ‎Feb 8, 2010‎
The data presented in June also showed that pixantrone had some other severe side effects including the depletion of white blood cells. ...

FDA Accepts Teva's XM02 for Neutropenia

Trading Markets (press release) - ‎22 hours ago‎
Neutropenia is a hematological disorder characterized by an abnormally low number of neutrophils, the a type of white blood cell in the blood. ...

Living With a Formerly Fatal Blood Cancer

New York Times - Jane E. Brody - ‎Jan 18, 2010‎
But now Barry's white blood cell count was through the roof. MUTATE Leukemia white blood cells, through a scanning electron microscope. ...

Tainted cocaine batches have health officials on high alert

CTV.ca - ‎Feb 8, 2010‎
"People can die from infections when they don't have white blood cells." Recovering drug addict Ryan Ouellete says he has heard of other instances of ...

How Blood Flow Force Protects Blood Vessels

Science Daily (press release) - ‎Jan 28, 2010‎
Fatty diets cause cholesterol deposits to build up within arterial walls, deposits that white blood cells "see" as infections and home in on to drive ...

Leukemia under the microscope

San Diego Union Tribune - Scott LaFee - ‎Feb 1, 2010‎
Leukemia covers a number of diseases related to bone-marrow cancers, in which white blood cells (leukocytes) divide uncontrollably and disrupt normal ...

FDA to review Teva biosimilar of Amgen's Neupogen

Reuters - Bill Berkrot, Gunna Dickson - ‎Feb 2, 2010‎
TA) said on Tuesday the US Food and Drug Administration will review its application to sell a biotechnology medicine to boost white blood cells that is ...
Teva Announces FDA Accepts BLA for XM02 Earthtimes (press release)

Lipoxen granted EU patent for polysialic acid technology StimuXen

Proactive Investors USA & Canada - ‎Feb 7, 2010‎
The technology aims at protecting the body's level of white blood cells which is particularly beneficial in chemotherapy patients. This technology is based ...

Study opens new path to fighting leukemia relapse

Reuters - Tan Ee Lyn, Alex Richardson - ‎Feb 3, 2010‎
AML is a disease where there is rapid growth of abnormal white blood cells, which cannot fight infections. Patients are not only susceptible to infections, ...
 -